Skip to main content

Clinical TrialsSearch 1M+ trials from global registries Drug IntelligenceFollow pipelines from discovery to approval

Global ApprovalsTrack regulatory decisions across 12+ agencies

US FDA Drugs EU EMA Drugs Singapore HSA Drugs China NMPA Drugs Australia TGA Drugs Canada HC Drugs Spain CIMA-AEMPS Drugs UK EMC Drugs Saudi SFDA Drugs Malaysia NPRA Drugs Philippines FDA Drugs Kenya PPB Drugs

AI-Powered ResearchDiscover powerful insights with advanced AI analysis tools for clinical trials.Learn more →Premium AccessGet unlimited access to our comprehensive pharmaceutical database and analytics.Subscribe →

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

新可来 - NMPA Drug Approval Details

Approvals/NMPA/Mepolizumab Injection

Approved

生物制品

Mepolizumab Injection

GLAXOSMITHKLINE TRADING SERVICES LIMITED🇨🇳 National Medical Products Administration

Approval Date: Dec 25, 2024
Approval ID: 8BYtsNkuP9l
Company: GLAXOSMITHKLINE TRADING SERVICES LIMITED
Type: 生物制品

Approval Details

Approval Id: 8BYtsNkuP9l
Approval Number: 国药准字SJ20210030
Generic Name: 美泊利珠单抗注射液
Generic Name En: Mepolizumab Injection
Trade Name: 新可来
Drug Type: 生物制品
Dosage Form: 注射剂
Strength: 100mg （1ml）/支（单剂量预充式安全注射器）
Reg Date: 2024-12-25
Expired Date: 2026-11-16
Company Name: GLAXOSMITHKLINE TRADING SERVICES LIMITED
Production Company Name: Glaxo Operations UK Ltd.
Company Detail Path: /organization/b0887c1b5fa94b86/glaxosmithkline-trading-services-limited
Production Company Detail Path: /organization/05c68751ebc60ba7/glaxo-operations-uk-ltd

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Dec 25, 2024

Approval ID

8BYtsNkuP9l

Type

生物制品

Back to NMPA Approvals